Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

2.95
-0.5141-14.84%
Post-market: 2.950.00000.00%18:07 EDT
Volume:54.64K
Turnover:174.59K
Market Cap:4.40M
PE:-1.05
High:3.63
Open:3.46
Low:2.92
Close:3.46
Loading ...
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 08, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 07, 2024

Correspondence

Form CORRESP - Correspondence
Feb 07, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 05, 2024

Correspondence

Form CORRESP - Correspondence
Jan 05, 2024

Correspondence

Form CORRESP - Correspondence
Jan 04, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 19, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 15, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 27, 2023

Major Issues Report

Form 8-K - Current report